risperidone has been researched along with lorazepam in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (10.42) | 18.2507 |
2000's | 26 (54.17) | 29.6817 |
2010's | 12 (25.00) | 24.3611 |
2020's | 5 (10.42) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Emes, CE; Millson, RC | 1 |
Zimbroff, DL | 1 |
Hillard, JR | 1 |
Bouman, NH; Dhossche, DM | 1 |
Chang, WH; Lane, HY; Su, KP | 1 |
Bader, PI; Cangany, N; Dougherty, S; Jackson, CE; Raymond, G | 1 |
Currier, GW; Simpson, GM | 1 |
Coletti, DJ; Dicker, R; Kafantaris, V; Kane, JM; Padula, G | 1 |
Beijnen, JH; Kerbusch, T; Mathôt, RA; Meesters, EW; Otten, HM; Schellens, JH; van Kan, HJ | 1 |
Cherry, D; Cummings, JL; Frank, JC; Hewett, L; Kemp, B; Kohatsu, ND; Mittman, B | 1 |
Allain, H; Bentué-Ferrer, D; Bouhours, P; Gandon, M; Le Breton, S; Tarral, A; Tessier, C | 1 |
Augustyns, I; Grossman, F; Ravindran, A; Vieta, E; Yatham, LN | 1 |
Bossie, CA; Chou, JC; Currier, GW; Feifel, D; Gharabawi, GM; Mahmoud, RA; Turkoz, I | 1 |
Chrzanowski, W; Karavatos, A; Larmo, I; Lejeune, J; Lex, A; Medori, R; Schreiner, A; Witte, R | 1 |
Englert, I | 1 |
Eerdekens, M; Grossman, F; Karcher, K; Khanna, S; Kramer, M; Smulevich, AB | 1 |
Dries, PJ; Hovens, JE; Loonen, AJ; Melman, CT; Wapenaar, RJ | 1 |
Currier, GW; McMullan, JT; Veser, BD; Veser, FH; Zealberg, J | 1 |
Arai, H; Hatta, K; Miyakawa, K; Nakamura, H; Ota, T; Usui, C | 1 |
Emsley, R; Koen, L; Medori, R; Niehaus, DJ; Oosthuizen, PP; Rabinowitz, J | 1 |
Athey, R; Forlano, R; Singh, D | 1 |
Casteels, M; de Vos, M; Laekeman, G; Reyntens, J; Zwaenepoel, L | 1 |
Kutscher, E; Peterson, E; Stoebner, A; Weatherill, J | 1 |
Bansal, V; Gupta, S; Kumar, S; Mowar, A; Sharma, S | 1 |
Fornaro, G; Ghio, L; Rossi, P | 1 |
Böker, H; Krähenmann, R; Küchenhoff, B; Schick, M | 1 |
Behere, RV; Danivas, V; Gangadhar, BN; Rao, NP; Varambally, S; Venkatasubramanian, G | 1 |
Fajardo, K; Grenier, E; John, V; Ko, E; Ryan, M | 1 |
Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F | 1 |
Kar, SK; Saxena, S; Trivedi, JK | 1 |
Csomor, PA; Geyer, MA; Huber, T; Preller, KH; Studerus, E; Vollenweider, FX | 1 |
Guru, S; Loganathan, S; Vanamoorthy, U; Varghese, M | 1 |
Erkuran, HÖ; Kutlu, A; Önen, Ö | 1 |
Aggarwal, N; Kataria, D; Prakash, R; Prasad, S | 1 |
Hernández-Salas, LP; Herrera-Huerta, CA; Magallanes-Cano, EM | 1 |
Barbe, N; Coffey, BJ; Miller, M; Poulsen, RJ | 1 |
Al Abdulla, M; Haddad, PM; Iqbal, Y; Latoo, J | 1 |
Faisal, M; O'Hanrahan, S; Pradeep, V | 1 |
Acheampong, D; Cardieri, B; Coffey, BJ; Crow, M; Rice, T | 1 |
3 review(s) available for risperidone and lorazepam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Emergency treatment of acute psychosis.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Emergency Services, Psychiatric; Emergency Treatment; Haloperidol; History, 20th Century; Humans; Lorazepam; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone | 1998 |
Guidelines for managing Alzheimer's disease: Part II. Treatment.
Topics: Advance Directives; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Disease Progression; Donepezil; Humans; Indans; Lorazepam; Patient Education as Topic; Phenylcarbamates; Piperidines; Risperidone; Rivastigmine | 2002 |
8 trial(s) available for risperidone and lorazepam
Article | Year |
---|---|
Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Electrooculography; Female; Humans; Lorazepam; Male; Memory; Psychomotor Performance; Risperidone | 2003 |
Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.
Topics: Adult; Aged; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Treatment Refusal; Valproic Acid | 2003 |
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Cluster Analysis; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Prospective Studies; Psychomotor Agitation; Risperidone; Severity of Illness Index; Single-Blind Method | 2004 |
Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Psychotic Disorders; Risperidone; Schizophrenia; Treatment Outcome | 2004 |
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Bipolar Disorder; Dopamine Antagonists; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Risperidone; Serotonin Antagonists; Time Factors; Treatment Outcome | 2005 |
Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
Topics: Adolescent; Adult; Aged; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Clopenthixol; Drug Therapy, Combination; Emergency Medical Services; Endpoint Determination; Female; Humans; Lorazepam; Male; Middle Aged; Personnel, Hospital; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Risperidone; Social Behavior | 2005 |
Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Pilot Projects; Prospective Studies; Psychomotor Agitation; Risperidone; Severity of Illness Index; Treatment Outcome | 2006 |
Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary study.
Topics: Adolescent; Adult; Antidepressive Agents; Blood Glucose; Body Mass Index; Cholesterol; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Injections; Lorazepam; Male; Pilot Projects; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Severity of Illness Index; Time Factors; Treatment Outcome; Weight Gain | 2008 |
37 other study(ies) available for risperidone and lorazepam
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Risperidone-induced priapism.
Topics: Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Humans; Isoxazoles; Lithium Carbonate; Lorazepam; Male; Middle Aged; Piperidines; Priapism; Risperidone; Schizophrenia, Paranoid | 1994 |
Switching patients from clozapine to risperidone therapy.
Topics: Antipsychotic Agents; Clonazepam; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoxazoles; Lorazepam; Piperidines; Risperidone; Schizophrenia; Substance Withdrawal Syndrome | 1995 |
Catatonia in an adolescent with Prader-Willi Syndrome.
Topics: Adolescent; Antipsychotic Agents; Catatonia; Haloperidol; Humans; Lorazepam; Male; Neurologic Examination; Neuropsychological Tests; Prader-Willi Syndrome; Risperidone; Treatment Outcome | 1997 |
Seizures after discontinuation of low-dose lorazepam from originally seizure-free clozapine regimen: combined effects?
Topics: Adult; Anti-Anxiety Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electroencephalography; Humans; Lorazepam; Male; Risperidone; Schizophrenia; Seizures; Substance Withdrawal Syndrome | 1999 |
Infantile refsum disease in four Amish sibs.
Topics: Adolescent; Antidepressive Agents; Child; Consanguinity; Female; Fluoxetine; Humans; Lorazepam; Male; Refsum Disease; Risperidone | 2000 |
Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Risperidone; Treatment Outcome; Violence | 2001 |
Adjunctive antipsychotic treatment of adolescents with bipolar psychosis.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Drug Therapy, Combination; Female; Humans; Lithium; Lorazepam; Male; Psychiatric Status Rating Scales; Risperidone; Severity of Illness Index | 2001 |
Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report.
Topics: Acute Disease; Acute Kidney Injury; Adult; Antimanic Agents; Antipsychotic Agents; Bayes Theorem; Bipolar Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Lithium; Lorazepam; Male; Models, Biological; Renal Dialysis; Risperidone; Suicide, Attempted | 2002 |
[Diphenhydramin-overdose: anticholinergic symptoms, EEG-findings in the course and drug treatment of a gerontopsychiatric patient].
Topics: Aged; Brain; Cholinergic Antagonists; Dementia; Depressive Disorder; Diphenhydramine; Drug Therapy, Combination; Electroencephalography; Histamine H1 Antagonists; Humans; Lorazepam; Male; Paranoid Disorders; Poisoning; Risperidone; Suicide, Attempted; Temazepam | 2004 |
Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Catatonia; Diazepam; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Lorazepam; Male; Middle Aged; Retreatment; Risperidone; Schizophrenia, Catatonic; Treatment Outcome | 2007 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Cholinesterase Inhibitors; Cognition Disorders; Creatine Kinase; Dementia; Disease Progression; Donepezil; Female; Humans; Indans; Lorazepam; Muscle Rigidity; Neuroleptic Malignant Syndrome; Olanzapine; Piperidines; Recurrence; Risperidone | 2008 |
Osteoporosis after combined use of a neuroleptic and antidepressants.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Drug Interactions; Female; Humans; Lorazepam; Middle Aged; Osteoporosis; Prolactin; Rib Fractures; Risperidone; Sertraline | 2008 |
Case of acute psychosis from herbal supplements.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dietary Supplements; Female; Haloperidol; Humans; Lorazepam; Plant Extracts; Psychoses, Substance-Induced; Risperidone; Treatment Outcome | 2008 |
Postoperative psychosis in an adolescent subsequent to oral surgical outpatient procedure.
Topics: Antipsychotic Agents; Dexamethasone; Female; Glucocorticoids; Humans; Injections, Intravenous; Lorazepam; Maxilla; Molar; Oral Surgical Procedures; Postoperative Complications; Psychoses, Substance-Induced; Radicular Cyst; Risperidone; Young Adult | 2009 |
Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
Topics: Antipsychotic Agents; Female; Humans; Hyperamylasemia; Injections, Intramuscular; Intubation, Gastrointestinal; Lipase; Lorazepam; Middle Aged; Neuroleptic Malignant Syndrome; Pancreatitis; Risperidone; Schizophrenia, Disorganized; Treatment Outcome; Urinary Catheterization | 2009 |
[Catatonic dilemma in a schizoaffective patient with combined lithium-risperidone administration].
Topics: Antimanic Agents; Antipsychotic Agents; Brain; Catatonia; Clozapine; Diagnosis, Differential; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electroencephalography; Humans; Hypnotics and Sedatives; Lithium Carbonate; Long-Term Care; Lorazepam; Male; Middle Aged; Psychotic Disorders; Risperidone; Serotonin | 2010 |
Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Female; Humans; Hypnotics and Sedatives; Lithium Compounds; Lorazepam; Male; Psychotic Disorders; Risperidone; Secondary Prevention; Syndrome; Young Adult | 2010 |
Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report.
Topics: Catatonia; Clonazepam; Drug Therapy, Combination; Female; Humans; Lorazepam; Risperidone; Young Adult | 2011 |
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Differential; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Lorazepam; Male; Olanzapine; Patient Admission; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Risperidone; Schizophrenia, Catatonic | 2013 |
Electroconvulsive treatment in catatonia of cerebrovasculo-coagulopathy: a case report.
Topics: Adult; Antipsychotic Agents; Catatonia; Cerebrovascular Disorders; Depression, Postpartum; Electroconvulsive Therapy; Female; GABA Modulators; Humans; Lorazepam; Nervous System Diseases; Risperidone; Thrombosis | 2013 |
Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.
Topics: Acoustic Stimulation; Amisulpride; Antipsychotic Agents; Aripiprazole; Auditory Perception; Benzhydryl Compounds; Brain; Double-Blind Method; Electroencephalography; Electromyography; Humans; Lorazepam; Male; Modafinil; Piperazines; Prepulse Inhibition; Psychometrics; Psychotropic Drugs; Quinolones; Risperidone; Sensory Gating; Sulpiride; Valproic Acid; Young Adult | 2014 |
Neuroleptic malignant syndrome following abrupt anti-cholinergic withdrawal: a case report.
Topics: Antipsychotic Agents; Cholinergic Antagonists; Female; Humans; Lorazepam; Neuroleptic Malignant Syndrome; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Trihexyphenidyl; Young Adult | 2014 |
Treating an Adolescent with Long QT Syndrome for Bipolar Disorder: A Case Presentation.
Topics: Adolescent; Bipolar Disorder; Female; Humans; Long QT Syndrome; Lorazepam; Risperidone; Valproic Acid | 2017 |
Meditation induced psychosis: Case report.
Topics: Adult; Antipsychotic Agents; GABA Modulators; Haloperidol; Humans; Lorazepam; Male; Meditation; Promethazine; Psychotic Disorders; Risperidone | 2018 |
Cycloid psychosis and its longitudinal diagnosis: case report.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Psychotic Disorders; Recurrence; Risperidone; Sertraline; Sleep Initiation and Maintenance Disorders | 2020 |
Overcoming Complications in Management of a Difficult-to-Treat Adolescent with Schizoaffective Disorder.
Topics: Adolescent; Adolescent Psychiatry; Antidepressive Agents; Antipsychotic Agents; Diphenhydramine; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Psychiatric Department, Hospital; Psychotic Disorders; Risperidone; Sertraline | 2020 |
Brief psychotic disorder associated with quarantine and mild COVID-19.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; COVID-19; Humans; Lorazepam; Male; Mirtazapine; Pandemics; Psychotic Disorders; Qatar; Quarantine; Risperidone; SARS-CoV-2 | 2020 |
Case of paediatric catatonia precipitated by antipsychotic withdrawal in a child with autism spectrum disorder.
Topics: Adolescent; Antipsychotic Agents; Autism Spectrum Disorder; Catatonia; Female; Humans; Lorazepam; Risperidone | 2021 |
High-Dose Benzodiazepines in Treatment of Malignant Catatonia in an Adolescent: Lorazepam, Clonazepam, and Differing Efficacy.
Topics: Adolescent; Anticonvulsants; Catatonia; Clonazepam; Humans; Lorazepam; Male; Risperidone; Treatment Outcome | 2021 |